PromaCare-TA / Tranexamic Acid

PromaCare-TA/ Sawirka Acid Tranexamic
  • PromaCare-TA / Tranexamic Acid

Sharaxaad Gaaban:

PromaCare-TA waa daroogo guud, wakiilka antifibrinolytic ee lama huraanka u ah liiska WHO. Waxaa loo isticmaalay sidii daawo dhaqameed oo dhiigbax ah. Waa daawo ka hortagta plasminogen ilaa plasmin ee dhiiga. Tranexamic acid waxay si tartan ah u joojisaa firfircoonida plasminogen (iyada oo la isku xidho qaybta kringle), taas oo hoos u dhigaysa beddelka plasminogen una beddelo plasmin (fibrinolysin), enzym hoos u dhiga xinjirowga fibrin, fibrinogen, iyo borotiinada kale ee balaasmaha, oo ay ku jiraan arrimaha procoagulant V iyo VIII. Tranexamic acid sidoo kale waxay si toos ah u joojisaa dhaqdhaqaaqa plasmin-ka, laakiin qiyaaso ka badan ayaa loo baahan yahay si loo yareeyo samaynta plasmin-ka.


Faahfaahinta Alaabta

Tags Product

 

Magaca ganacsiga PromaCare-TA
CAS 1197-18-8
Magaca Alaabta Tranexamic acid
Qaab-dhismeedka Kiimikada
Codsiga Daawo
Xidhmada 25kgs net halkii durbaan
Muuqashada Caddaan ama ku dhawaad ​​cad, awoodda crystalline
Qiimayn 99.0-101.0%
Solubility Biyo milmaya
Nolosha shelf 4 sano
Kaydinta Weelka si adag u xidh oo meel qabow dhig. Ka ilaali kulaylka.

Codsiga

Tranexamic acid, oo sidoo kale loo yaqaano xinjirowga, waa amino acid antifibrinolytic, oo ah mid ka mid ah daawooyinka xinjirowga lidka ku ah inta badan lagu isticmaalo rugta caafimaadka.

Alaabtan waxaa loo isticmaali karaa:

1. Dhiigbaxa dhaawaca ama qaliinka ee prostate, kaadi mareenka, sambabada, maskaxda, ilmo galeenka, qanjidhada adrenal, thyroid, beerka iyo xubnaha kale ee hodanka ku ah firfircoonida plasminogen.

2. Waxa loo isticmaalaa sida wakiilada thrombolytic, sida unugyada plasminogen activator (t-PA), streptokinase iyo urokinase antagonist.

3. Soo rididda ilmo soo rididda, ka-baxa mandheerta, bakhtida dhalmada iyo embolismka dheecaanka amniotic ee uu keeno dhiig-baxa fibrinolytic.

4. Menorrhagia, dhiigbaxa qolka hore iyo epistaxis daran oo leh fibrinolysis maxalli ah oo kordhay.

5. Waxa loo isticmaalaa si looga hortago ama loo yareeyo dhiig-baxa ka dib marka iliga la soo saaro ama qalliin afka ah ee bukaannada hemophilic ee leh cillad VIII ama factor IX.

6. Alaabtani waxay ka sarraysaa dawooyinka kale ee antifibrinolytic ee hemostasis of hemorrhage khafiif ah oo ay keento dillaaca aneurysm dhexe, sida dhiigbaxa subarachnoid iyo dhiigbaxa intracranial aneurysm. Si kastaba ha ahaatee, waa in fiiro gaar ah loo yeesho khatarta bararka maskaxda ama wadna xanuunka maskaxda. Marka loo eego bukaannada daran ee leh calaamadaha qalliinka, alaabtan waxaa loo isticmaali karaa oo kaliya sidii adjuvant.

7. Daawaynta bararka xididdada dhiigga ee la iska dhaxlo, waxay yarayn kartaa tirada weerarada iyo darnaanta.

8. Bukaanka qaba hemophilia waxay leeyihiin dhiig-bax firfircoon.

9. Waxay saamayn daawaynta qeexan ku leedahay chloasma.

  • Kii hore:
  • Xiga:

    • Alaabooyinka LA XIRIIRA